Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1971 Oct;64(10):1031–1038. doi: 10.1177/003591577106401011

Treatment of rheumatic disorders with special reference to ankylosing spondylitis.

R J Sinclair
PMCID: PMC1812751  PMID: 4947524

Full text

PDF
1031

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK R. L., O'BRIEN W. M., VANSCOTT E. J., AUERBACH R., EISEN A. Z., BUNIM J. J. METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS. JAMA. 1964 Sep 7;189:743–747. [PubMed] [Google Scholar]
  2. Baum J., Vaughan J. Immunosuppressive drugs in rheumatoid arthritis. Ann Intern Med. 1969 Jul;71(1):202–204. doi: 10.7326/0003-4819-71-1-202. [DOI] [PubMed] [Google Scholar]
  3. Bean R. H. Phenylbutazone and Leukaemia. Br Med J. 1960 Nov 26;2(5212):1552–1555. doi: 10.1136/bmj.2.5212.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown W. M., Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J. 1965 Dec 4;2(5474):1327–1332. doi: 10.1136/bmj.2.5474.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CAMPBELL A. H., MACDONALD C. B. UPPER LOBE FIBROSIS ASSOCIATED WITH ANKYLOSING SPONDYLITIS. Br J Dis Chest. 1965 Apr;59:90–101. doi: 10.1016/s0007-0971(65)80017-1. [DOI] [PubMed] [Google Scholar]
  6. CHALMERS T. M., MCCARTHY D. D. PHENYLBUTAZONE THERAPY ASSOCIATED WITH LEUKAEMIA. Br Med J. 1964 Mar 21;1(5385):747–747. doi: 10.1136/bmj.1.5385.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CRUICKSHANK B. Pathology of ankylosing spondylitis. Bull Rheum Dis. 1960 Mar;10:211–214. [PubMed] [Google Scholar]
  8. Calabro J. J., Amante C. M. Indomethacin in ankylosing spondylitis. Arthritis Rheum. 1968 Feb;11(1):56–64. doi: 10.1002/art.1780110108. [DOI] [PubMed] [Google Scholar]
  9. Denman E. J., Denman A. M., Greenwood B. M., Gall D., Heath R. B. Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis. 1970 May;29(3):220–231. doi: 10.1136/ard.29.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Emery A. E., Lawrence J. S. Genetics of ankylosing spondylitis. J Med Genet. 1967 Dec;4(4):239–244. doi: 10.1136/jmg.4.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fosdick W. M., Parsons J. L., Hill D. F. Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum. 1968 Apr;11(2):151–161. doi: 10.1002/art.1780110205. [DOI] [PubMed] [Google Scholar]
  12. Freyberg R. H., Block W. D., Levey S. METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE. J Clin Invest. 1941 Jul;20(4):401–412. doi: 10.1172/JCI101235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jessamine A. G. Upper lung lobe fibrosis in ankylosing spondylitis. Can Med Assoc J. 1968 Jan 6;98(1):25–29. [PMC free article] [PubMed] [Google Scholar]
  14. Jessop J. D. Gold in rheumatoid arthritis. Br Med J. 1971 Jan 2;1(5739):49–50. doi: 10.1136/bmj.1.5739.49-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KELLY M. History of immobilization. Rheumatism. 1962 Apr;18:27–32. [PubMed] [Google Scholar]
  16. Krusius F. E., Markkanen A., Peltola P. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Ann Rheum Dis. 1970 May;29(3):232–235. doi: 10.1136/ard.29.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lionel N. D., Herxheimer A. Assessing reports of therapeutic trials. Br Med J. 1970 Sep 12;3(5723):637–640. doi: 10.1136/bmj.3.5723.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mason M., Currey H. L., Barnes C. G., Dunne J. F., Hazleman B. L., Strickland I. D. Azathioprine in rheumatoid arthritis. Br Med J. 1969 Feb 15;1(5641):420–422. doi: 10.1136/bmj.1.5641.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nanra R. S., Kincaid-Smith P. Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br Med J. 1970 Sep 5;3(5722):559–561. doi: 10.1136/bmj.3.5722.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. O'CONNELL D. Ankylosing spondylitis; the literature up to the close of the nineteenth century. Ann Rheum Dis. 1956 Jun;15(2):119–123. doi: 10.1136/ard.15.2.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Partridge R. E., Duthie J. J. Controlled Trial of the Effect of Complete Immobilization of the Joints in Rheumatoid Arthritis. Ann Rheum Dis. 1963 Mar;22(2):91–99. doi: 10.1136/ard.22.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Proudfoot A. T., Wright N. Acute paracetamol poisoning. Br Med J. 1970 Sep 5;3(5722):557–558. doi: 10.1136/bmj.3.5722.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Smyth C. J. Indomethacin--its rightful place in treatment. Ann Intern Med. 1970 Mar;72(3):430–432. doi: 10.7326/0003-4819-72-3-430. [DOI] [PubMed] [Google Scholar]
  24. VAN SWAAY H. Aplastic anaemia and myeloid leukaemia after irradiation of the vertebral column. Lancet. 1955 Jul 30;269(6883):225–227. doi: 10.1016/s0140-6736(55)92215-7. [DOI] [PubMed] [Google Scholar]
  25. WOODLIFF H. J., DOUGAN L. ACUTE LEUKAEMIA ASSOCIATED WITH PHENYLBUTAZONE TREATMENT. Br Med J. 1964 Mar 21;1(5385):744–746. doi: 10.1136/bmj.1.5385.744. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES